The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.
An early-stage clinical trial of an experimental Ebola vaccine found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses
The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.
An early-stage clinical trial of an experimental Ebola vaccine found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses
